Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00800813 · ClinicalTrials.gov registry record

Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
121
Enrollment target

NCT00800813: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00800813 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 121 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00800813 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
121 participants
Enrollment target

Study Summary

Some men complain of changes in the shape or dimensions of their penis after undergoing radical prostatectomy (removal of the prostate) for prostate cancer. Changes in penile dimensions include shortening or decreased girth. Changes in shape include a curvature or bending of the penis, and/or the appearance of indentation. These changes may be associated with formation of scar tissue involving the covering of the erection chambers, known as "plaque". The appearance of indurated plaque and a resultant curvature or indentation is a well described medical condition known as "Peyronie's Disease" and may occur in men who did or did not undergo radical prostatectomy. The purpose of this study is to evaluate these changes in penile shape and dimensions.

Interventions

  • BEHAVIORAL Penile Exam, Peyronie's Plaque and Erectile function assessment

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2008-11
Est. Completion 2014-07
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00800813 record still lists

NCT00800813 is an observational study that tracks outcomes without assigning an intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Penile Exam, Peyronie's Plaque and Erectile function assessment is the first listed.

NCT00800813 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00800813 about?

NCT00800813 is a clinical study titled "Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy". Some men complain of changes in the shape or dimensions of their penis after undergoing radical prostatectomy (removal of the prostate) for prostate cancer. Changes in penile dimensions include shortening or decreased girth. Changes in shape include a curvature or bending of the penis, and/or the ap...

What is the current status of trial NCT00800813?

This trial is currently completed. The enrollment target is 121 participants. The study started on 2008-11. Estimated completion is 2014-07.

What interventions are being tested in trial NCT00800813?

The interventions under investigation include: Penile Exam, Peyronie's Plaque and Erectile function assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00800813?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03476681 · 121 participants · Phase 1

    Study of NEO-201 in Solid Tumors Expansion Cohorts

  • NCT04655118 · 121 participants · Phase 2

    Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

  • NCT04676802 · 121 participants · Phase 2

    Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

  • NCT05169515 · 121 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00800813, the US trial registry maintained by the National Library of Medicine. NCT00800813 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.